Aug 19, 2024, 10:29
New ELN classification of AML receiving less intense therapies
Eddie Cliff, Haematology Registrar at Peter MacCallum Cancer Centre, shared a post on X about a recent paper by Hartmut Döhner et al. published in Blood Journal.
Authors: Hartmut Döhner, Courtney DiNardo, Andrew Wei, Jianxiang Wang, Agnieszka Wierzbowska et al.
“Just out in Blood Journal – new ELN classification of AML receiving less intense therapies – we discuss this classification in our upcoming Blood Cancer Talks episode with Prof. Andrew Wei.”
Source: Eddie Cliff/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 13, 2024, 09:39
Nov 13, 2024, 08:59
Nov 13, 2024, 08:39